Univariate and multivariate regression analysis of disease-free survival in each data set
| Variables | Univariate analysis | Multivariate analysis | ||||
| HR | 95% CI of HR | P value | HR | 95% CI of HR | P value | |
| GSE30219 | ||||||
| TILSig (high/low) | 2.000 | 1.373 to 2.914 | <0.001 | 1.570 | 1.062 to 2.320 | 0.024 |
| Age | 1.021 | 1.004 to 1.038 | 0.017 | 1.019 | 1.000 to 1.037 | 0.045 |
| Gender (male/female) | 1.355 | 0.787 to 2.333 | 0.273 | 1.216 | 0.704 to 2.100 | 0.484 |
| Stage (III/IV vs I/II) | 3.959 | 2.685 to 5.837 | <0.001 | 3.583 | 2.411 to 5.326 | <0.001 |
| GSE31210 | ||||||
| TILSig (high/low) | 1.863 | 1.136 to 3.053 | 0.014 | 1.728 | 1.043 to 2.863 | 0.034 |
| Age | 1.034 | 0.997 to 1.072 | 0.074 | 1.039 | 1.003 to 1.077 | 0.0342 |
| Gender (male/female) | 1.271 | 0.778 to 2.075 | 0.338 | 1.012 | 0.609 to 1.682 | 0.964 |
| Stage (II /I) | 3.164 | 1.921 to 5.213 | <0.001 | 3.280 | 1.968 to 5.466 | <0.001 |
TILSig, tumor-infiltrating immune-related lncRNA signature.